The Greater Cambridge Health Tech Connect University Enterprise Zone (UEZ) brings together the Cambridge cluster to stimulate collaborations and create a platform for cross-fertilisation of ideas and projects.

It aims to facilitate interactions between scientists, companies, entrepreneurs, research-exchange, acceleration and incubation activities between innovation hubs.

UEZ provides a cross-discipline initiative within the life and physical sciences and deliver activities across three market application-driven strands therapeutics, medical technologies and digital health.

Host: Astex/ Greater Cambridge Health Tech Connect UEZ

Date: 23 July 2020

Location: This event will take place online and webinar details will follow closer to the time

Programme:

18:00 – Welcome

18:05 – Dr Raj Jena, Group Leader, Machine Learning & Radiomics in Radiation Therapy

RadNet Cambridge – exploring research potential for novel drug combinations with radiation therapy

18:30 – Dr Su Metcalfe, Co-PI University of Cambridge Clinical School; Founder and CEO LIFNanoRx Ltd

Exploiting the Power of Stem Cells using Nanotechnology: Multiple Sclerosis & COVID-19

18:50 – Dr Chris Proctor, Group Leader, Department of Engineering and Dr Damiano Barone, NIHR Academic Clinical Lecturer in Neurosurgery, Department of Clinical Neuroscience

Bioelectronics for targeted therapy

19:10 – 3 breakout-facilitated sessions with the presenters (~30 min)- During this session, attendees will have the opportunity to discuss a range of topics suggested by the speaker. Further details of these facilitated discussions will follow closer to the time. On the registration page, please indicate which session you would like to join. Links to the breakout rooms will be circulated prior to the event and attendees will be able to join the room of their choice.

Questions for breakout sessions:

1) Dr Raj Jena

o What proportion of UK cancer patients are cured of cancer with radiation therapy as the main treatment, compared to drug therapy

o In 10 years, what classes of therapeutics will we be using with radiation therapy

2) Dr Su Metcalfe

o Blood-Brain Barrier (BBB)

o Clinical stage SME with Disruptive Technology entering billion dollar Pharma Markets

o Aligning with the Regulators

3) Drs Chris Proctor and Damiano Barone

o Applications for local drug delivery and controlled release

o Biomarkers for smart therapeutics

o Role of neural interfaces in patients' therapy

o Ethical issues in neural interfaces.